Cheddani, Halima <br/><br/>
Cancer in Elderly Onset Inflammatory Bowel Disease: A Population-Based Study.  [electronic resource] 

 -  The American journal of gastroenterology  Oct 2016 
 - 1428-1436 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1572-0241 
<br/><br/><label>Standard No.: </label>10.1038/ajg.2016.304  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adrenal Cortex Hormones--therapeutic use<br/>Age of Onset<br/>Aged<br/>Aged, 80 and over<br/>Anti-Inflammatory Agents, Non-Steroidal--therapeutic use<br/>Azathioprine--therapeutic use<br/>Carcinoma--epidemiology<br/>Colitis, Ulcerative--drug therapy<br/>Colorectal Neoplasms--epidemiology<br/>Crohn Disease--drug therapy<br/>Female<br/>Follow-Up Studies<br/>France--epidemiology<br/>Humans<br/>Immunosuppressive Agents--therapeutic use<br/>Incidence<br/>Inflammatory Bowel Diseases--drug therapy<br/>Intestinal Neoplasms--epidemiology<br/>Lymphoproliferative Disorders--epidemiology<br/>Male<br/>Mesalamine--therapeutic use<br/>Methotrexate--therapeutic use<br/>Middle Aged<br/>Myeloproliferative Disorders--epidemiology<br/>Neoplasms--epidemiology<br/>Proportional Hazards Models<br/>Protective Factors<br/>Registries<br/>Retrospective Studies<br/>Risk Factors<br/>Time Factors<br/>Tumor Necrosis Factor-alpha--antagonists & inhibitors